Quest Magazine

DMD: Sarepta Updates Community on Eteplirsen, Other Compounds

MG: Multicenter Trial of Rituximab Opens

First Drug for Duchenne Muscular Dystrophy Gets 'Conditional Approval' in Europe

DMD: Ataluren Receives Conditional Approval in Europe

PTC Therapeutics Receives Conditional Approval in the European Union for Translarna™ for the treatment of Nonsense Mutation Duchenne Muscular Dystrophy

ISIS-SMNRx to Be Tested in Phase 3 Trial in Infants With SMA

Safeway Inc. and The Safeway Foundation Fundraising Campaign to Support Programs for People with Disabilities

Jiffy Lube® Supports Fight Against Muscle Disease With Third Annual MUSCLE UP® Campaign

Fire Fighters and MDA Celebrate “60 Years Strong”

DMD: ReveraGen Drug Will Move to Human Testing

Pages